Genetix Biotherapeutics
AcquiredGenetic Medicine for Rare Diseases
Somerville, United States · Founded 1992
- Headquarters
- Somerville, Massachusetts
- Founded
- 1992
- Business Model
- B2B
- Website
- genetixbiotx.com
- Acquisition Date
- Jun 2025
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Genetix Biotherapeutics (formerly bluebird bio) is a commercial-stage biotechnology company delivering genetic therapies for patients with sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. Its FDA-approved, one-time administered therapies are based on a patient's own blood stem cells, modified outside the body to add working copies of an affected gene before being returned to restore normal gene function. Headquartered in Somerville, Massachusetts, the company traces its roots to 1992, when it was founded as Genetix Pharmaceuticals before rebranding to bluebird bio in 2010 and returning to the Genetix name in 2025.
Summary
Genetix Biotherapeutics is a Biotech company based in Somerville, United States, founded in 1992. Investors include The Carlyle Group.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Jun 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genetix-biotherapeutics"><img src="https://indexed.vc/api/badge/company/genetix-biotherapeutics" alt="Genetix Biotherapeutics on Indexed.vc" width="260" height="76" /></a>